These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 36003673

  • 1. Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors.
    Ren H, Leon SJ, Whitlock R, Rigatto C, Komenda P, Bohm C, Collister D, Tangri N.
    Clin Kidney J; 2022 Sep; 15(9):1713-1719. PubMed ID: 36003673
    [Abstract] [Full Text] [Related]

  • 2. Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada.
    Atiquzzaman M, Birks P, Bevilacqua M, Wong MMY, Zheng Y, Djurdjev O, Levin A.
    Can J Kidney Health Dis; 2022 Sep; 9():20543581221137177. PubMed ID: 36406867
    [Abstract] [Full Text] [Related]

  • 3. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020 Sep; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

  • 4. RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study.
    Riccio E, Capuano I, Buonanno P, Andreucci M, Provenzano M, Amicone M, Rizzo M, Pisani A.
    Front Cardiovasc Med; 2022 Sep; 9():824095. PubMed ID: 35224054
    [Abstract] [Full Text] [Related]

  • 5. Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study.
    Jun M, Jardine MJ, Perkovic V, Pilard Q, Billot L, Rodgers A, Rogers K, Gallagher M.
    PLoS One; 2019 Sep; 14(3):e0213192. PubMed ID: 30845156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE.
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization.
    Desai NR, Rowan CG, Alvarez PJ, Fogli J, Toto RD.
    PLoS One; 2020 Dec; 15(1):e0226844. PubMed ID: 31910208
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of hyperkalemia in patients with chronic kidney disease: a comparison of calcium polystyrene sulphonate and sodium polystyrene sulphonate.
    Nasir K, Ahmad A.
    J Ayub Med Coll Abbottabad; 2014 Dec; 26(4):455-8. PubMed ID: 25672163
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease.
    Kim GH.
    Electrolyte Blood Press; 2019 Jun; 17(1):1-6. PubMed ID: 31338108
    [Abstract] [Full Text] [Related]

  • 14. Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
    Agiro A, An A, Cook EE, Mu F, Chen J, Desai P, Oluwatosin Y, Pollack CV.
    Adv Ther; 2023 Jun; 40(6):2886-2901. PubMed ID: 37140706
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.